GB0124030D0 - Novel polypeptide - Google Patents

Novel polypeptide

Info

Publication number
GB0124030D0
GB0124030D0 GBGB0124030.8A GB0124030A GB0124030D0 GB 0124030 D0 GB0124030 D0 GB 0124030D0 GB 0124030 A GB0124030 A GB 0124030A GB 0124030 D0 GB0124030 D0 GB 0124030D0
Authority
GB
United Kingdom
Prior art keywords
novel polypeptide
polypeptide
novel
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
GBGB0124030.8A
Other versions
GB2371302A (en
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Glaxo Group Ltd
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of GB0124030D0 publication Critical patent/GB0124030D0/en
Publication of GB2371302A publication Critical patent/GB2371302A/en
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Psychiatry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Pain & Pain Management (AREA)
  • Addiction (AREA)
  • Hospice & Palliative Care (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
GB0124030A 2000-10-05 2001-10-05 Neurotransmitter transporter polypeptide Withdrawn GB2371302A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0024447.5A GB0024447D0 (en) 2000-10-05 2000-10-05 Novel Polypeptide

Publications (2)

Publication Number Publication Date
GB0124030D0 true GB0124030D0 (en) 2001-11-28
GB2371302A GB2371302A (en) 2002-07-24

Family

ID=9900756

Family Applications (2)

Application Number Title Priority Date Filing Date
GBGB0024447.5A Ceased GB0024447D0 (en) 2000-10-05 2000-10-05 Novel Polypeptide
GB0124030A Withdrawn GB2371302A (en) 2000-10-05 2001-10-05 Neurotransmitter transporter polypeptide

Family Applications Before (1)

Application Number Title Priority Date Filing Date
GBGB0024447.5A Ceased GB0024447D0 (en) 2000-10-05 2000-10-05 Novel Polypeptide

Country Status (1)

Country Link
GB (2) GB0024447D0 (en)

Also Published As

Publication number Publication date
GB2371302A (en) 2002-07-24
GB0024447D0 (en) 2000-11-22

Similar Documents

Publication Publication Date Title
AU8441801A (en) Novel polypeptide
GB0003079D0 (en) Novel protein
GB0015761D0 (en) Polypeptide
GB0127017D0 (en) New polypeptide
GB0120704D0 (en) Polypeptide
GB0025572D0 (en) New polypeptide
EP1354947A4 (en) Novel polypeptide
GB0027537D0 (en) New polypeptide
GB0013239D0 (en) Polypeptide
GB0012199D0 (en) New polypeptide
GB0030855D0 (en) Novel polypeptide
GB0012248D0 (en) Novel polypeptide
GB0031304D0 (en) Novel polypeptide
GB0024447D0 (en) Novel Polypeptide
GB0009070D0 (en) Novel polypeptide
GB0009973D0 (en) Novel polypeptide
GB0014827D0 (en) Novel polypeptide
GB0015203D0 (en) Novel polypeptide
GB0030854D0 (en) Novel polypeptide
GB0026839D0 (en) Novel polypeptide
GB0018238D0 (en) Novel polypeptide
EP1323731A4 (en) Novel peptides
GB0021524D0 (en) Polypeptide
GB0030293D0 (en) Polypeptide
GB0027166D0 (en) Polypeptide

Legal Events

Date Code Title Description
WAP Application withdrawn, taken to be withdrawn or refused ** after publication under section 16(1)